Shinya Suzuki

Chief Pharmacist

National Cancer Center Hospital

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shinya Suzuki is the Chief Pharmacist at the National Cancer Center Hospital East in Japan. His research interests include the effects of immune checkpoint inhibitors on thyroid dysfunction, the safety and efficacy of dermatological treatments for cancer patients, and the management of opioid-related respiratory depression. Additionally, he has contributed to studies on drug regimen checks performed by pharmacists and the impact of baseline blood pressure on cancer treatment outcomes.

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (2)

Kazuko Tajiri

Chief

JAPAN

View details

Makoto Tahara

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shinya Suzuki

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Effects of Immune Checkpoint Inhibitor-induced Thyroid Dysfunction on Cardiac Troponin Levels

Efficacy and safety of adapalene gel as a reactive treatment for cetuximab-induced skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck: A historical cohort comparison study

Opioid-Related Respiratory Depression in Non-Cancer Patients, as Reported in the Japanese Adverse Drug Event Report Database.

Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey

Association between baseline blood pressure and the incidence of lenvatinib‐induced hypertension in patients with thyroid cancer

Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study

Planned drug holidays during treatment with lenvatinib for radioiodine-refractory differentiated thyroid cancer: a retrospective study

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer

A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer

Multicenter prospective observational study on hospital pharmacist interventions to reduce inappropriate medications

Collaborators (2)

Kazuko Tajiri

Makoto Tahara

Make your next move.